Adipokines 2.0

Once viewed solely as fat storage cells, adipocytes and their adipokines have now been proven to be central for human health. Understanding that overweight and obesity may increase the risk for various diseases requires detailed characterization of adipokine function. Weight gain, weight regain, and...

Full description

Saved in:
Bibliographic Details
:
Year of Publication:2020
Language:English
Physical Description:1 electronic resource (406 p.)
Tags: Add Tag
No Tags, Be the first to tag this record!
LEADER 05073nam-a2201321z--4500
001 993548485704498
005 20231214132837.0
006 m o d
007 cr|mn|---annan
008 202102s2020 xx |||||o ||| 0|eng d
020 |a 3-03928-587-4 
035 |a (CKB)4100000011302218 
035 |a (oapen)https://directory.doabooks.org/handle/20.500.12854/40131 
035 |a (EXLCZ)994100000011302218 
041 0 |a eng 
100 1 |a Büchler, Christa  |4 auth 
245 1 0 |a Adipokines 2.0 
260 |b MDPI - Multidisciplinary Digital Publishing Institute  |c 2020 
300 |a 1 electronic resource (406 p.) 
336 |a text  |b txt  |2 rdacontent 
337 |a computer  |b c  |2 rdamedia 
338 |a online resource  |b cr  |2 rdacarrier 
506 |a Open access  |f Unrestricted online access  |2 star 
520 |a Once viewed solely as fat storage cells, adipocytes and their adipokines have now been proven to be central for human health. Understanding that overweight and obesity may increase the risk for various diseases requires detailed characterization of adipokine function. Weight gain, weight regain, and fasting affect adipocyte health and accordingly their secretome. Different adipose tissue deposits exist and they vary in cellular composition and function. The evidence is strong of a role of adipokines in cancer, reproductive function, neurological diseases, cardiovascular diseases ,and rheumatoid arthritis. Adipokines are considered useful biomarkers for adipose tissue and metabolic health, and may be used as diagnostic tools in rheumatoid arthritis, cancer, or sepsis. This book contains 10 original articles and 9 review articles focusing on these bioactive peptides. Several articles deal with chemerin, an adipokine discovered more than 20 years ago. Data so far have resulted in promising insights related to its biological function. We are only beginning to understand the multiple roles of chemerin, the mechanisms regulating its activity, and the signaling pathways used by this chemokine. Adipokine receptor agonists and antagonists may result in the formulation of novel drugs and ultimately may lead to new therapeutic targets to be used in clinical practice. 
546 |a English 
653 |a lipids 
653 |a cathepsins 
653 |a neurodegeneration 
653 |a tocilizumab 
653 |a SGBS adipocytes 
653 |a chemerin receptors 
653 |a cholesterol 
653 |a metabolically healthy obese 
653 |a energy metabolism 
653 |a adipose-brain axis 
653 |a EP3 receptor 
653 |a leptin 
653 |a rheumatoid arthritis 
653 |a excessive gestational weight gain 
653 |a in vitro fat regain 
653 |a secreted frizzled-related protein 5 
653 |a PCOS 
653 |a EP4 receptor 
653 |a leukocyte 
653 |a exchange protein directly activated by cAMP isoform 2 (EPAC2) 
653 |a extracellular remodeling 
653 |a insulin 
653 |a osteoarthritis 
653 |a lipid metabolism 
653 |a fat mass 
653 |a Tango bioassay 
653 |a fatty liver 
653 |a free fatty acids 
653 |a label-free proteomic profiling 
653 |a interleukin(IL)-33 
653 |a sick fat 
653 |a polycystic ovary syndrome 
653 |a early-life programming 
653 |a inflammation 
653 |a gestational diabetes 
653 |a glucose restriction 
653 |a adipokines 
653 |a neonatal anthropometry 
653 |a epicardial adipose tissue (EAT) 
653 |a oestrous cycle 
653 |a Cardiovascular Diseases (CVDs) 
653 |a triglycerides 
653 |a G protein-coupled receptor 1 
653 |a testicular pathologies 
653 |a prognosis 
653 |a ovary 
653 |a ICU 
653 |a biologic activity 
653 |a preeclempsia 
653 |a adipokine 
653 |a critical illness 
653 |a early pregnancy 
653 |a myokine 
653 |a liver steatosis 
653 |a C-C chemokine receptor-like 2 
653 |a testis 
653 |a stimulating growth factor 2 (ST2) 
653 |a pig 
653 |a fitness 
653 |a human granulosa cells 
653 |a obesity 
653 |a proteolysis 
653 |a annexins 
653 |a adipose tissue 
653 |a biomarker 
653 |a ghrelin 
653 |a brain health 
653 |a sepsis 
653 |a adiponectin 
653 |a rheumatic diseases 
653 |a chemokine-like receptor 1 
653 |a follicular fluid 
653 |a glucose homeostasis 
653 |a resistin 
653 |a Nonalcoholic fatty liver disease 
653 |a prostaglandin E2 (PGE2) 
653 |a visceral fat 
653 |a microglia 
653 |a weight regain 
653 |a complement factors 
653 |a alpha-fetoprotein 
653 |a polycystic ovary morphology 
653 |a chemerin 
653 |a cancer 
653 |a depression 
653 |a hypertension 
653 |a hypothalamus 
776 |z 3-03928-586-6 
906 |a BOOK 
ADM |b 2023-12-15 05:33:24 Europe/Vienna  |f system  |c marc21  |a 2020-06-20 22:16:43 Europe/Vienna  |g false 
AVE |i DOAB Directory of Open Access Books  |P DOAB Directory of Open Access Books  |x https://eu02.alma.exlibrisgroup.com/view/uresolver/43ACC_OEAW/openurl?u.ignore_date_coverage=true&portfolio_pid=5338828230004498&Force_direct=true  |Z 5338828230004498  |b Available  |8 5338828230004498